Login

Journal Front Page

News & Events

  • April 2024 Issue delayed
    • Dear Researcher, It Pleased to inform you that, Asian Journal of Pharmaceutical Education and Research, Volume 13, Issue 2 (April 2024) Issue) schedule published on 15 April 2024 is delay due to some technical problem. It will published on 22 April 2024. Sorry for inconvenience. For other details You can vist the website http://www.ajper.com
  • Call for article for April 2024 issue
    • Submissions of Review, Research Article, Short Communication and Case study are being accepted for the current and future issues before 15 March, 2024 of this journal by online process or editor@ajper.com, or ajper.editor@gmail.com. Further information can be found at www.ajper.com.
  • January 2024 Issue published
    • Dear Researcher, It Pleased to inform you that, Asian Journal of Pharmaceutical Education and Research, has successfully launch Volume 13, Issue 1 (January 2024) Issue). You can find the article on http://ajper.com/current_issue.php Article also invited for the Next coming Issue from your side. For More details Visit: www.ajper.com
  • Application For Reviewer
    • We are now going to reconstitute our editorial board members of Reviewer. Please send your resume at ajper.editor@gmail.com and be a part of the editorial board member as Reviewer.
  • AJPER Impact facor
    • It is to pleasure that Ajper SJIF imact facor has increse from 5.019 to 7.014. Also global impact factor incresed from 0.654 to 0.765.
  • ICV
    • AJPER Rank with Index Copernicus Value 61.10 due to high reputation at International Level

Abstract

DEVELOPMENT AND CHARACTERIZATION OF ACYCLOVIR LOADED LIPOSOME USING ROTARY FLASH EVAPORATION TECHNIQUE

Mansi Gupta*, Arti Vishwakarma

Technocrats Institute of technology- Pharmacy, Bhopal (M.P.) Pin- 462021, India

ABSTRACT

The objective of the present study is to form liposomal based acyclovir ointment. Acyclovir, an antiviral drug is widely used in the treatment of herpes simplex (types 1 and 2). Acyclovir is a synthetic purine nucleoside analogue with in vitro and in vivo inhibitor activity against herpes simplex virus types 1(HSV-1), 2 (HSV-2) and varicellazoster virus (VZV) that occurs at epidermis. The oral bioavailability of acyclovir is low. Five formulations of liposomal carrier for Acyclovir prepared for the treatment of viral infections that is capable of delivering the drug to the specific target site by topical route by using different ratios of phospholipids and cholesterol with a desired amount of drug by rotary flash evaporation technique. and to find out the drug entrapment from the liposome's of different ratios, drug release pattern and also to find out the size distribution of liposome's of different ratios and also to increase the bioavailability and efficacy of the drug.

Keywords: Herpes Simplex Virus (HSV), Varicella-Zoster Virus (VZV), Acyclovir (ACV).


[Full Text Article]